(PharmaNewsWire.Com, August 10, 2017 ) Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “ Non-Small Cell Lung Cancer -Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Non-Small Cell Lung Cancer. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Non-Small Cell Lung Cancer by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Market Research Hub`s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Scope of the report
The report provides a snapshot of the pipeline development for the Non-Small Cell Lung Cancer The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Non-Small Cell Lung Cancer The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non-Small Cell Lung Cancer The report also covers the dormant and discontinued pipeline projects related to the Non-Small Cell Lung Cancer
Reasons to Buy
Establish comprehensive understanding of the pipeline activity across this Non-Small Cell Lung Cancer to formulate effective R&D strategies Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Non-Small Cell Lung Cancer therapeutics Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress
Report Introduction 2. Non-Small Cell Lung Cancer Overview 3. Pipeline Therapeutics An Overview of Pipeline Products for Non-Small Cell Lung Cancer 4. Comparative Analysis 5. Products in Clinical Stage 5.1 Drug Name : Company Name Product Description Research and Development Product Development Activities 6. Products in Pre-Clinical and Discovery Stage 6.1 Drug Name : Company Name Product Description Research and Development Product Development Activities 7. Therapeutic Assessment Assessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type 8. Inactive Products 8.1 Drug Name : Company Name Product Description Research and Development Product Development Activities Appendix Report Methodology Consulting Services Disclaimer About Market Research Hub
List of Table
Table 1:Total Products for Non-Small Cell Lung Cancer Table 2: Products in Clinical Stage Table 3: Products in Pre-Clinical and Discovery Stage Table 4: Assessment by Route of Administration Table 5: Assessment by Stage and Route of Administration Table 6: Assessment by Molecule Type Table 7: Assessment by Stage and Molecule Type Table 8: Inactive Products
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
